PT Communication Cable Systems Indonesia Tbk (IDX:CCSI)
Indonesia · Delayed Price · Currency is IDR 320.00
+4.00 (1.27%)
Aug 1, 2025, 4:14 PM WIB
Theseus Pharmaceuticals Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2020 |
| 294,133 | 291,365 | 349,501 | 615,332 | 422,883 | 282,013 | Upgrade | |
Revenue Growth (YoY) | 2.21% | -16.63% | -43.20% | 45.51% | 49.95% | -26.09% | Upgrade |
Cost of Revenue | 242,105 | 240,646 | 321,901 | 496,446 | 325,216 | 206,024 | Upgrade |
Gross Profit | 52,028 | 50,719 | 27,600 | 118,886 | 97,667 | 75,989 | Upgrade |
Selling, General & Admin | 35,506 | 36,337 | 44,269 | 46,536 | 44,997 | 40,316 | Upgrade |
Operating Expenses | 35,506 | 36,337 | 44,269 | 46,536 | 44,997 | 40,316 | Upgrade |
Operating Income | 16,522 | 14,381 | -16,669 | 72,350 | 52,670 | 35,673 | Upgrade |
Interest Expense | -8,247 | -9,428 | -13,776 | -5,970 | -2,507 | -3,595 | Upgrade |
Interest & Investment Income | 1,162 | 807.55 | 110.17 | 77.68 | 1,398 | 3,103 | Upgrade |
Currency Exchange Gain (Loss) | -347.81 | -1,758 | 3,511 | -6,617 | 54.98 | -1.71 | Upgrade |
Other Non Operating Income (Expenses) | -1,256 | -1,286 | -1,299 | -780.93 | 287.54 | -1.32 | Upgrade |
EBT Excluding Unusual Items | 7,833 | 2,717 | -28,123 | 59,060 | 51,903 | 35,178 | Upgrade |
Gain (Loss) on Sale of Assets | 6.38 | -221.96 | -0.13 | -3.64 | - | - | Upgrade |
Pretax Income | 7,839 | 2,495 | -28,123 | 59,056 | 51,903 | 35,178 | Upgrade |
Income Tax Expense | -31.62 | -1,407 | -5,747 | 14,566 | 13,170 | 6,655 | Upgrade |
Earnings From Continuing Operations | 7,871 | 3,903 | -22,377 | 44,491 | 38,734 | 28,523 | Upgrade |
Minority Interest in Earnings | -10.79 | 0.05 | 0 | - | - | - | Upgrade |
Net Income | 7,860 | 3,903 | -22,377 | 44,491 | 38,734 | 28,523 | Upgrade |
Net Income to Common | 7,860 | 3,903 | -22,377 | 44,491 | 38,734 | 28,523 | Upgrade |
Net Income Growth | - | - | - | 14.86% | 35.80% | -48.63% | Upgrade |
Shares Outstanding (Basic) | 1,233 | 1,200 | 1,200 | 1,200 | 1,200 | 1,200 | Upgrade |
Shares Outstanding (Diluted) | 1,233 | 1,200 | 1,200 | 1,200 | 1,200 | 1,200 | Upgrade |
Shares Change (YoY) | 2.79% | - | - | - | - | 10.21% | Upgrade |
EPS (Basic) | 6.37 | 3.25 | -18.65 | 37.08 | 32.28 | 23.77 | Upgrade |
EPS (Diluted) | 6.37 | 3.25 | -18.65 | 37.08 | 32.28 | 23.77 | Upgrade |
EPS Growth | - | - | - | 14.86% | 35.80% | -53.39% | Upgrade |
Free Cash Flow | 47,907 | 37,001 | -22,424 | -74,690 | -53,082 | 13,639 | Upgrade |
Free Cash Flow Per Share | 38.84 | 30.83 | -18.69 | -62.24 | -44.23 | 11.37 | Upgrade |
Dividend Per Share | - | - | - | - | 7.500 | 6.250 | Upgrade |
Dividend Growth | - | - | - | - | 20.00% | - | Upgrade |
Gross Margin | 17.69% | 17.41% | 7.90% | 19.32% | 23.09% | 26.95% | Upgrade |
Operating Margin | 5.62% | 4.94% | -4.77% | 11.76% | 12.46% | 12.65% | Upgrade |
Profit Margin | 2.67% | 1.34% | -6.40% | 7.23% | 9.16% | 10.11% | Upgrade |
Free Cash Flow Margin | 16.29% | 12.70% | -6.42% | -12.14% | -12.55% | 4.84% | Upgrade |
EBITDA | 35,236 | 32,529 | 2,173 | 88,955 | 67,610 | 49,164 | Upgrade |
EBITDA Margin | 11.98% | 11.16% | 0.62% | 14.46% | 15.99% | 17.43% | Upgrade |
D&A For EBITDA | 18,714 | 18,148 | 18,842 | 16,605 | 14,940 | 13,491 | Upgrade |
EBIT | 16,522 | 14,381 | -16,669 | 72,350 | 52,670 | 35,673 | Upgrade |
EBIT Margin | 5.62% | 4.94% | -4.77% | 11.76% | 12.46% | 12.65% | Upgrade |
Effective Tax Rate | - | - | - | 24.66% | 25.37% | 18.92% | Upgrade |
Advertising Expenses | - | 339.61 | 607.29 | 880.14 | 191.48 | 18.58 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.